865833-72-3

Basic information

• Product Name: [1-(trifluoromethyl)cyclopropyl]methyl-4-methylbenzene-1-sulfonate
• Synonyms: [1-(trifluoromethyl)cyclopropyl]methyl-4-methylbenzene-1-sulfonate
• CAS NO: 865833-72-3
• Molecular Weight: 294.295
• Mol File: 865833-72-3.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: [1-(trifluoromethyl)cyclopropyl]methyl-4-methylbenzene-1-sulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: [1-(trifluoromethyl)cyclopropyl]methyl-4-methylbenzene-1-sulfonate(865833-72-3)
• EPA Substance Registry System: [1-(trifluoromethyl)cyclopropyl]methyl-4-methylbenzene-1-sulfonate(865833-72-3)

Safety Data

• Hazardous Substances Data: 865833-72-3(Hazardous Substances Data)

Upstream product

• 277756-46-4 1-(trifluoromethyl)cyclopropanecarboxylic acid 
• 98-59-9 p-toluenesulfonyl chloride 
• 371917-17-8 1-Hydroxymethyl-1-(trifluoromethyl)cyclopropane 

Downstream Products

• 1360569-00-1 4-bromo-1-chloro-2-(4-((1-(trifluoromethyl)cyclopropyl)methoxy)benzyl)benzene 
• 1360569-39-6 (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((1-(trifluoromethyl)cyclopropyl)methoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1360569-40-9 (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-((1-(trifluoromethyl)cyclopropyl)methoxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 1360569-45-4 (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-fluoro-3-(4-((1-(trifluoromethyl)cyclopropyl)methoxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 1360569-46-5 (2S,3R,4R,5S,6R)-2-(4-fluoro-3-(4-((1-(trifluoromethyl)cyclopropyl)methoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1360569-10-3 (3R,4S,5S,6R)-2-(4-fluoro-3-(4-((1-( trifluoromethyl)cyclopropyl)methoxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol 
• 1360569-11-4 (3R,4R,5S,6R)-2-(4-fluoro-3-(4-((1-(trifluoromethyl)cyclopropyl)methoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1360569-32-9 (2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-(4-methyl-3-(4-((1-(trifluoromethyl)cyclopropyl)methoxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1360569-09-0 4-bromo-1-fluoro-2-(4-((1-(trifluoromethyl)cyclopropyl)methoxy)benzyl)benzene 
• 2229861-17-8 2-chloro-6-[3-[[1-(trifluoromethyl)cyclopropyl]methoxymethyl]pyrazol-1-yl]pyridine-3-carboxylic acid 

Relevant articles and documents

SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

The invention provides substituted imidazole carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat a medical disorder, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.

5-(PYRIDIN-3-YL)OXAZOLE ALLOSTERIC MODULATORS OF M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

Provided are 5-(pyridin-3-yl) oxazole compounds, the compositions comprising these compounds and the uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities

Described are compounds of Formula I which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c-FMS, c-KIT, or PDGFR kinases.